Tech Transfer to Commercialization:

Fueling the Region's Economic Growth Engine

 

 

Agenda

 

8:00 a.m.

Registration/Breakfast/Networking

8:30 a.m.

Conference Begins

Welcome - Leslie Browne, Chair, NJTC Board of Directors and
President & CEO, Pharmacopeia

Keynote Speaker:

Elizabeth Tallett, Principal, Hunter Partners, LLC
Introduced by Beth Cohen, Dir. Emerging Growth Services, WolfBlock

9:15 a.m. - 12:30 p.m.

University to Start Up

Moderated by: Patricia Weeks, VP Planning & Business Development, Fox Chase Cancer Center

Panelists: Karen Hanson, Executive Director, BioStrategy Partners
Michael Cleare, Associate Vice Provost for Research, University of Pennsylvania
Michel Bitritto, President, NJ Business Incubation Network
Janet George Murnick, President, UV Solutions
Vincent Smeraglia, Director of Licensing, UMDNJ

Universities are frequently the seedbed of startup companies. In nearly all cases, universities provide the initial intellectual property protection for an emerging, and typically, embryonic technology. This panel will explore the various steps academic institutions might take and/or resources they can call upon to add value to a technology and push it along the continuum to a successful startup. The panelists will also comment on common pitfalls to be avoided on the pathway

The Adolescent Company

Moderated by: Tom Morr, President & CEO, Select Greater Philadelphia

Panelists: Todd Abrams, Director, Philanthropy and Business Development, Lankenau Institute for Medical Research
Carol Marino, VP, Venture Investments, J&J Development Corp
David Niles,Vice President, TCA Brokerage Services, Trinity Capital Advisors, LLC
Vincent Sette, CEO, Great American Technologies

This panel will describe the issues facing the beginning company that is established but not quite ready for investment. It may still be virtual or in a university or free standing incubator, but has received some early funding, has a business plan, an experienced CEO and is getting ready to launch a product. A number of opportunities and pitfalls still face this nascent organization

Commercialization to Market

Moderated By: Beth Cohen, Dir. Emerging Growth Services, WolfBlock

Panelists: Chris Cushing, Vice Chairman, WolfBlock Public Strategies
Bertold Fridlender, CEO, Phytomedics
Beverly Lubit, Partner, Intell. Property, WolfBlock
Patrick Foley, Managing Director, Delaware Innovation Fund
Tracy Warren, General Partner, Battelle Ventures, LP/Innovation Valley Partners, LP
Bjornulf White, Manager of Business Development, Lockheed Martin Corporation

This panel will focus on the the challenges and opportunities faced by both life science and technology entrepreneurs as they enter the commercial markets with their products, including: raising capital; launching the product; opportunities to sell to the government; legal issues; and more. Panelists will consist of entrepreneurs, investors, and government marketing experts

12:45 p.m.

Luncheon Speaker:

Robert Hugin, President & COO, Celgene Corporation

Introduced by Caren Franzini, CEO, NJEDA